Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,055Revenue $M0Net Margin (%)0Z-Score
Enterprise Value $M1,053EPS $0Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %ROA % (ttm)0Higher Current Ratio y-yN
Dividend Yield %1.5Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M0ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with VHT

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VHTKen Fisher 2013-12-31 Buy $91.43 - $97.64
($95.51)
$ 125.8832%New holding, 3028 sh.3,028
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VHT is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


VHT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Harris, Michael DeaneDirector 2014-12-23Buy870$7.281617.03view
Hoffman, MichaelDirector 2014-12-23Buy2,000$0.05249900view
Cruise, BrydonDirector 2014-12-22Buy400$14.38769.26view
Porter, MarkSenior Officer 2014-12-22Sell47,000$31303.23view
Tobin, Sr., James JosephSenior Officer 2014-12-22Sell96,491$106.9716.86view
Hoffman, MichaelDirector 2014-12-22Buy48,000$0.05249900view
Eaton, William DouglasDirector or Senior Officer of 10% Security Holder 2014-12-22Buy19,000$0249900view
Labine, Daniel AlbertSenior Officer 2014-12-22Buy8,000$1.0511804.76view
Eaton, William DouglasSenior Officer 2014-12-22Buy2,000$011804.76view
Berlet, Christopher JamesSenior Officer 2014-12-22Sell40,000$0.2159423.81view

Press Releases about VHT :

    Quarterly/Annual Reports about VHT:

      News about VHT:

      Articles On GuruFocus.com
      No related article found.

      More From Other Websites
      Momentum, Thy Name is Healthcare? Dec 21 2014
      The New Tech: Changing Sector Behavior Over Time Dec 19 2014
      Top Ranked Healthcare ETFs in Focus Dec 08 2014
      Healthcare ETFs for Long Term Investors Dec 03 2014
      Defensive ETFs to Diversify an Investment Portfolio Nov 16 2014
      Which Health Care ETF Should You Buy? Nov 13 2014
      Vanguard ETFs Eschew Daily Disclosure Oct 29 2014
      Healthcare ETFs for your Portfolio's Wellness Sep 26 2014
      Healthcare ETFs to For a Healthy Investment Portfolio Sep 19 2014
      Health Care ETFs Outpacing Market Sep 14 2014
      Consumer Spending Has Salubrious Effect on Healthcare ETFs Sep 11 2014
      Two Market Leading Sectors Aug 25 2014
      COLUMN-Healthcare: A remedy for long-term investors Aug 04 2014
      How Obamacare Will Boost Your Portfolio Jun 30 2014
      Aging stinks, so at least make some money from it Jun 23 2014
      Forces Shaping The Global Health-Care Industry May 20 2014
      'Defensive Stocks' Are Not Much Help In Market Downturns May 09 2014
      Are Retail Stocks Too Expensive? Apr 11 2014
      3 Obamacare-Related ETFs To Watch Mar 21 2014
      ETF Sector Rotation: Industrials Out, Healthcare In Mar 11 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK